A collagen–hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
An emerging paradigm in orthopedics is that a bone-healing outcome is the product of the anabolic (bone-forming) and catabolic (bone-resorbing) outcomes. Recently, surgical and tissue engineering strategies have emerged that combine recombinant human bone morphogenetic proteins (rhBMPs) and bisphosphonates (BPs) in order to maximize anabolism and minimize catabolism. Collagen-based scaffolds that are the current surgical standard can bind rhBMPs, but not BPs. We hypothesized that a biomimetic collagen-hydroxyapatite (CHA) scaffold would bind both agents and produce superior in vivo outcomes. Consistent with this concept, in vitro elution studies utilizing rhBMP-2 ELISA assays and scintillation counting of (14)C-radiolabeled zoledronic acid (ZA) confirmed delayed release of both agents from the CHA scaffold. Next, scaffolds were tested for their capacity to form ectopic bone after surgical implantation into the rat hind limb. Using CHA, a significant 6-fold increase in bone volume was seen in rhBMP-2/ZA groups compared to rhBMP-2 alone, confirming the ability of ZA to enhance rhBMP-2 bone formation. CHA scaffolds were found to be capable of generating mineralized tissue in the absence of rhBMP-2. This study has implications for future clinical treatments of critical bone defects. It demonstrates the relative advantages of co-delivering anabolic and anti-catabolic agents using a multicomponent scaffold system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giannoudis, P. V., Dinopoulos, H., & Tsiridis, E. (2005) · Injury · doi:10.1016/j.injury.2005.07.029 · Cited by 2,078
Nancollas, G. H., Tang, R., Phipps, R. J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R. G. G., & Ebetino, F. H. (2006) · Bone · doi:10.1016/j.bone.2005.05.003 · Cited by 862
Cited by
Advancing biomaterials of human origin for tissue engineering
Chen, F.-M., & Liu, X. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.02.004 · Cited by 1,158
In Vitro Mineralization of Collagen
Oosterlaken, B. M., Vena, M. P., & de With, G. (2021) · Advanced Materials · doi:10.1002/adma.202004418 · Cited by 231
Lin, K.-F., He, S., Song, Y., Wang, C.-M., Gao, Y., Li, J.-Q., Tang, P., Wang, Z., Bi, L., & Pei, G.-X. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00815 · Cited by 176
Raina, D. B., Matuszewski, L.-M., Vater, C., Bolte, J., Isaksson, H., Lidgren, L., Tägil, M., & Zwingenberger, S. (2020) · Science Advances · doi:10.1126/sciadv.abc1779 · Cited by 74
Tuning Dual-Drug Release from Composite Scaffolds for Bone Regeneration
Paris, J. L., Román, J., Manzano, M., Cabañas, M. V., & Vallet-Regí, M. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.048 · Cited by 41
Metadata
- Authors
- Murphy, C. M., Schindeler, A., Gleeson, J. P., Yu, N. Y. C., Cantrill, L. C., Mikulec, K., Peacock, L., O’Brien, F. J., & Little, D. G.
- Venue
- Acta Biomaterialia
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 10
- Issue
- 5
- Pages
- 2250-2258
- ISSN
- 1742-7061 (ISSN-L)
- OpenAlex
- W1975280273
- Cited by
- 119
- References
- 2
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A collagen–hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates. https://app.cochat.ai/papers/10.1016/j.actbio.2014.01.016
- The paper
- Murphy, C. M., Schindeler, A., Gleeson, J. P., Yu, N. Y. C., Cantrill, L. C., Mikulec, K., Peacock, L., O’Brien, F. J., & Little, D. G. (2014). A collagen–hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2014.01.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.